FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stanley Cryz

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Co-author Network

Publications

TOP 3
Narain H Punjabi; Emily L Richie; Cyrus H Simanjuntak; Sri Juliani Harjanto; Ferry Wangsasaputra; Soemarjati Arjoso; Ainur Rofiq; Mulyati Prijanto; Ursula Yela; Christian Herzog; Stanley J Cryz
Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
J B McClain; Robert Edelman; MJ Shmuklarsky; John U Que; Stanley J Cryz; Alan S Cross
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion.
Herwig Kollaritsch; Stanley J Cryz; Alois B Lang; Christian Herzog; John U Que; Gerhard Wiedermann
Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stanley Cryz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Narain H Punjabi; Emily L Richie; Cyrus H Simanjuntak; Sri Juliani Harjanto; Ferry Wangsasaputra; Soemarjati Arjoso; Ainur Rofiq; Mulyati Prijanto; Ursula Yela; Christian Herzog; Stanley J Cryz
Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Vaccine 2006;24(11):1776-85.
2001: J B McClain; Robert Edelman; MJ Shmuklarsky; John U Que; Stanley J Cryz; Alan S Cross
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion.
Vaccine 2001;19(25-26):3499-508.
2000: Herwig Kollaritsch; Stanley J Cryz; Alois B Lang; Christian Herzog; John U Que; Gerhard Wiedermann
Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization.
Vaccine 2000;18(26):3031-9.
2000: E E Richie; Narain H Punjabi; Y Y Sidharta; K K Peetosutan; M M Sukandar; Steven Wasserman; Murad Lesmana; Ferry Wangsasaputra; S S Pandam; Myron M Levine; P P O'Hanley; Stanley J Cryz; Cyrus H Simanjuntak
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.
Vaccine 2000;18(22):2399-410.
2000: Reinhard Glück; R Mischler; P Durrer; Emil Fürer; Alois B Lang; Christian Herzog; Stanley J Cryz
Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant.
The Journal of infectious diseases 2000;181(3):1129-32.
2000: D A Dilts; I Riesenfeld-Orn; J P Fulginiti; E Ekwall; C Granert; J Nonenmacher; R N Brey; Stanley J Cryz; K Karlsson; K Bergman; T Thompson; B Hu; A H Brückner; A A Lindberg
Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity.
Vaccine 2000;18(15):1473-84.
2000: C Panpitpat; U Thisyakorn; Tawee Chotpitayasunondh; Emil Fürer; John U Que; T Hasler; Stanley J Cryz
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Bulletin of the World Health Organization 2000;78(3):364-71.
1999: Arye Rubinstein; Y Mizrachi; Massimo Pettoello-Mantovani; Jack Lenz; G Q Liu; Y Rubinstein; Harris Goldstein; Israel Yust; Michael Burke; Nurith Vardinon; Z Spirer; Stanley J Cryz
Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates.
Journal of acquired immune deficiency syndromes (1999) 1999;22(5):467-76.
1999: Carol O Tacket; Mitchell B Cohen; Steven Wasserman; Genevieve A Losonsky; Sofie Livio; Karen L Kotloff; Robert Edelman; James B Kaper; Stanley J Cryz; Ralph A Giannella; Gilbert Schiff; Myron M Levine
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Infection and immunity 1999;67(12):6341-5.
1999: Myron M Levine; C Ferreccio; paulina abrego; O S Martin; E Ortiz; Stanley J Cryz
Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.
Vaccine 1999;17 Suppl 2():S22-7.
1999: Alan S Cross; Steven M Opal; Apurba K Bhattacharjee; S T Donta; Peter Peduzzi; Emil Fürer; John U Que; Stanley J Cryz
Immunotherapy of sepsis: flawed concept or faulty implementation?
Vaccine 1999;17 Suppl 2():S13-21.
1999: Stanley J Cryz
BERNA: a century of immunobiological innovation.
Vaccine 1999;17 Suppl 2():S1-5.
1999: Jean-François Viret; Didier Favre; B Wegmüller; Christian Herzog; John U Que; Stanley J Cryz; Alois B Lang
Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
Infection and immunity 1999;67(7):3680-5.
1999: David N Taylor; J L Sanchez; J M Castro; Carlos LeBron; C M Parrado; D E Johnson; Carol O Tacket; Genevieve A Losonsky; Steven Wasserman; Myron M Levine; Stanley J Cryz
Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.
Infection and immunity 1999;67(4):2030-4.
1999: Emily L Richie; Narain H Punjabi; S J Harjanto; F Wangsasaputral; M Sukandar; M Supriatman; Cyrus H Simanjuntak; John U Que; Stanley J Cryz
Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.
Vaccine 1999;17(11-12):1384-93.
1999: T F Tsai; Herwig Kollaritsch; John U Que; Cecil B Cropp; C Kunz; Gerhard Wiedermann; Christian Herzog; Stanley J Cryz
Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
The Journal of infectious diseases 1999;179(2):522-4.
1998: Maria Saurwein-Teissl; K Zisterer; TL Schmitt; R Glück; Stanley J Cryz; Beatrix Grubeck-Loebenstein
Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.
Clinical and experimental immunology 1998;114(2):271-6.
1998: David J Fryauff; Stanley J Cryz; Hendra Widjaja; E Mouzin; L.W. Preston Church; M Awalludin Sutamihardja; Allen L Richards; Budi Subianto; Stephen L Hoffman
Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis.
The Journal of infectious diseases 1998;177(6):1762-5.
1998: Stanley J Cryz
Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a.
Journal of travel medicine 1998;5(1):14-7.
1998: S Schwarzer; S Reibel; Alois B Lang; M M Struck; B Finkel; E Gerike; Annedore Tischer; M Gassner; Reinhard Glück; B Stück; Stanley J Cryz
Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines.
Vaccine 1998;16(2-3):298-304.
1998: Maria Saurwein-Teissl; MM Steger; R Glück; Stanley J Cryz; Beatrix Grubeck-Loebenstein
Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for the H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains.
Vaccine 1998;16(2-3):196-200.
1998: Stanley J Cryz; Reinhard Glück
Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
Developments in biological standardization 1998;92():219-23.
1997: Pierre Conne; Laurent Gauthey; P Vernet; B Althaus; John U Que; B Finkel; Reinhard Glück; Stanley J Cryz
Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients.
Vaccine 1997;15(15):1675-9.
1997: David N Taylor; Carol O Tacket; Genevieve A Losonsky; O Castro; J Gutierrez; Rina Meza; James P Nataro; James B Kaper; Steven Wasserman; Robert Edelman; Myron M Levine; Stanley J Cryz
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
Infection and immunity 1997;65(9):3852-6.
1997: Christian Herzog; B Wegmüller; Stanley J Cryz
Live oral cholera vaccine.
Lancet 1997;349(9067):1772-3.
1997: Herwig Kollaritsch; John U Que; C Kunz; Gerhard Wiedermann; Christian Herzog; Stanley J Cryz
Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine.
The Journal of infectious diseases 1997;175(4):871-5.
1997: Tawee Chotpitayasunondh; C Panpitpat; U Thisyakorn; E Furer; John U Que; T Hasler; Stanley J Cryz
Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
The Southeast Asian journal of tropical medicine and public health 1997;28(1):91-8.
1997: Stanley J Cryz; A Lang; Anna Rüdeberg; J Wedgwood; John U Que; Emil Fürer; Urs B Schaad
Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Behring Institute Mitteilungen 1997;(98):345-9.
1997: Helle Krogh Johansen; Stanley J Cryz; Hans Petter Hougen; Claus Moser; Niels Høiby
Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Behring Institute Mitteilungen 1997;(98):269-73.
1996: Stanley J Cryz; John U Que; Reinhard Glück
A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans.
Vaccine 1996;14(14):1381-3.
1996: Deborah J Briggs; D W Dreesen; P Morgan; J E Chin; C D Seedle; L Cryz; R Glück; Stanley J Cryz
Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults.
Vaccine 1996;14(14):1361-5.
1996: S T Donta; Peter Peduzzi; Alan S Cross; J Sadoff; C Haakenson; Stanley J Cryz; Carol A Kauffman; Suzanne F Bradley; G Gafford; D Elliston; T R Beam; J F John; Bruce RIBNER; R Cantey; C H Welsh; Richard Ellison; E J Young; Richard J Hamill; H Leaf; Roland M H Schein; M Mulligan; C Johnson; E Abrutyn; J M Griffiss; D Slagle
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
The Journal of infectious diseases 1996;174(3):537-43.
1996: D Favre; Stanley J Cryz; J F Viret
Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139.
Infection and immunity 1996;64(9):3565-70.
1996: W N Campbell; E Hendrix; Stanley J Cryz; Alan S Cross
Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(1):179-81.
1996: J A Sherwood; R S Copeland; K A Taylor; K Abok; James OLOO; J B Were; G Thomas Strickland; Daniel M Gordon; W Ripley Ballou; J D Bales; R A Wirtz; J Wittes; M Gross; J U Que; Stanley J Cryz; Charles N Oster; C R Roberts; J C Sadoff
Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.
Vaccine 1996;14(8):817-27.
1996: Stanley J Cryz; S S Davis; G Gregoriadis; J A Grimaud; P Kourilsky; M E Selkirk; M Slaoui; G L Smith
European Commission COST/STD Initiative. Report of the expert panel VII. Vaccine delivery systems.
Vaccine 1996;14(7):665-90.
1996: D Favre; M M Struck; Stanley J Cryz; J F Viret
Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR.
Vaccine 1996;14(6):526-31.
1996: Herwig Kollaritsch; E Furer; Christian Herzog; Gerhard Wiedermann; John U Que; Stanley J Cryz
Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.
Infection and immunity 1996;64(4):1454-7.
1996: J F Viret; Stanley J Cryz; D Favre
Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae.
Molecular microbiology 1996;19(5):949-63.
1996: D Favre; Stanley J Cryz; J F Viret
Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide.
Infection and immunity 1996;64(2):576-84.
1996: Stanley J Cryz; O Pasteris; S J Varallyay; Emil Fürer
Factors influencing the stability of live oral attenuated bacterial vaccines.
Developments in biological standardization 1996;87():277-81.
1995: A B Lang; U B Schaad; A Rüdeberg; J Wedgwood; John U Que; Emil Fürer; Stanley J Cryz
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
The Journal of pediatrics 1995;127(5):711-7.
1995: Helle Krogh Johansen; Hans Petter Hougen; Stanley J Cryz; Jørgen Rygaard; Niels Høiby
Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats.
American journal of respiratory and critical care medicine 1995;152(4 Pt 1):1337-46.
1995: yong poovorawan; Apiradee Theamboonlers; S Chumdermpadetsuk; R Glück; Stanley J Cryz
Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais.
Vaccine 1995;13(10):891-3.
1995: Stanley J Cryz; John U Que; Myron M Levine; Gerhard Wiedermann; Herwig Kollaritsch
Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
Infection and immunity 1995;63(4):1336-9.
1995: Stanley J Cryz; J O Que; Alan S Cross; Emil Fürer
Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine.
Vaccine 1995;13(5):449-53.
1995: Henry Wilde; R Glueck; Pakamatz Khawplod; Stanley J Cryz; Terapong Tantawichien; P Thipkong; Pranee Chomchey; S Prakongsri; Maneerat Benjavongkulchai; A Sumboonanondha
Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients.
Vaccine 1995;13(6):593-6.
1995: yong poovorawan; Apiradee Theamboonlers; L Vimolkej; Stanley J Cryz
Anti-hepatitis A antibody titers after passive immunization with hepatitis A hyperimmune globulin.
The Southeast Asian journal of tropical medicine and public health 1995;26(1):193-4.
1995: Arye Rubinstein; Harris Goldstein; M Pettoello-Mantovani; Y Mizrachi; Barry R Bloom; E Furer; B Althaus; John U Que; T Hasler; Stanley J Cryz
Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
AIDS (London, England) 1995;9(3):243-51.
1995: R Lagos; A Avendaño; V Prado; I Horwitz; S Wasserman; Genevieve A Losonsky; Stanley J Cryz; James B Kaper; Myron M Levine
Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
Infection and immunity 1995;63(2):707-9.
1995: Arye Rubinstein; Stanley J Cryz
Preventive and therapeutic AIDS peptide vaccines.
European journal of pediatrics 1995;154(9 Suppl 4):S28-9.
1995: Stanley J Cryz; James B Kaper; Carol O Tacket; James P Nataro; Myron M Levine
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.
Developments in biological standardization 1995;84():237-44.
1995: Stanley J Cryz; Harris Goldstein; M Pettoello-Mantovani; A Kim; Emil Fürer; John U Que; T Hasler; Arye Rubinstein
Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine.
Vaccine 1995;13(1):67-71.
1995: Carol O Tacket; Genevieve A Losonsky; James P Nataro; Steven Wasserman; Stanley J Cryz; Robert Edelman; Myron M Levine
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(1):75-7.
1994: Robert Edelman; David N Taylor; Steven Wasserman; J B McClain; Alan S Cross; J C Sadoff; John U Que; Stanley J Cryz
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.
Vaccine 1994;12(14):1288-94.
1994: Alan S Cross; A Artenstein; John U Que; T Fredeking; E Furer; J C Sadoff; Stanley J Cryz
Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers.
The Journal of infectious diseases 1994;170(4):834-40.
1994: Helle Krogh Johansen; Frank Espersen; Stanley J Cryz; Hans Petter Hougen; A Fomsgaard; Jørgen Rygaard; Niels Høiby
Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.
Infection and immunity 1994;62(8):3146-55.
1994: Reinhard Glück; R Mischler; B Finkel; John U Que; B Scarpa; Stanley J Cryz
Immunogenicity of new virosome influenza vaccine in elderly people.
Lancet 1994;344(8916):160-3.
1994: Helle Krogh Johansen; Stanley J Cryz; Niels Høiby
Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1994;102(7):545-53.
1994: Stanley J Cryz; J Wedgwood; A B Lang; A Ruedeberg; John U Que; Emil Fürer; U B Schaad
Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.
The Journal of infectious diseases 1994;169(5):1159-62.
1994: yong poovorawan; A Tieamboonlers; S Chumdermpadetsuk; R Glück; Stanley J Cryz
Control of a hepatitis A outbreak by active immunization of high-risk susceptible subjects.
The Journal of infectious diseases 1994;169(1):228-9.
1994: Arye Rubinstein; Harris Goldstein; M Pettoello-Mantovani; Stanley J Cryz
Preliminary results of V3 loop peptide-primary neutralizing domain conjugate phase 1 vaccine trail.
AIDS research and human retroviruses 1994;10 Suppl 2():S149-53.
1993: Carol O Tacket; Genevieve A Losonsky; James P Nataro; Stanley J Cryz; Robert Edelman; Alessio Fasano; Jane Michalski; James B Kaper; Myron M Levine
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
The Journal of infectious diseases 1993;168(6):1536-40.
1993: P Barrett; P Clarke; Stanley J Cryz
Oral cholera vaccine well tolerated.
BMJ (Clinical research ed.) 1993;307(6916):1425.
1993: Stanley J Cryz; Harris Goldstein; Emil Fürer; John U Que; T Hasler; B Althaus; Arye Rubinstein
Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization.
Annals of the New York Academy of Sciences 1993;693():194-201.
1993: Harri Saxen; Jaana Vuopio-Varkila; J Luk; A Lindberg; A Lang; F Di Padova; Stanley J Cryz; J Mertsola; George H McCracken; E J Hansen
Detection of enterobacterial lipopolysaccharides and experimental endotoxemia by means of an immunolimulus assay using both serotype-specific and cross-reactive antibodies.
The Journal of infectious diseases 1993;168(2):393-9.
1993: R Lagos; A Avendaño; I Horwitz; V Prado; C Ferreccio; V Sotomayor; Genevieve A Losonsky; Steven Wasserman; Stanley J Cryz; James B Kaper
[Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].
Revista médica de Chile 1993;121(8):857-63.
1993: A B Lang; Stanley J Cryz; U Schürch; M T Ganss; U Bruderer
Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(1):466-72.
1993: A B Lang; Emil Fürer; Stanley J Cryz
Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodies.
FEMS immunology and medical microbiology 1993;7(1):9-13.
1993: A Brauner; Stanley J Cryz; M Granström; H S Hanson; L Löfstrand; B Strandvik; B Wretlind
Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(6):430-6.
1993: Stanley J Cryz; N Vanprapar; U Thisyakorn; T Olanratmanee; Genevieve A Losonsky; Myron M Levine; S Chearskul
Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.
Infection and immunity 1993;61(3):1149-51.
1993: D E Schiff; C A Wass; Stanley J Cryz; Alan S Cross; Kwang S Kim
Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.
Infection and immunity 1993;61(3):975-80.
1993: Stanley J Cryz
Post-marketing experience with live oral Ty21a vaccine.
Lancet 1993;341(8836):49-50.
1993: J F Viret; Stanley J Cryz; A B Lang; D Favre
Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
Molecular microbiology 1993;7(2):239-52.
1992: Reinhard Glück; R Mischler; S Brantschen; M Just; B Althaus; Stanley J Cryz
Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
The Journal of clinical investigation 1992;90(6):2491-5.
1992: Carol O Tacket; Genevieve A Losonsky; James P Nataro; Stanley J Cryz; Robert Edelman; James B Kaper; Myron M Levine
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 1992;166(4):837-41.
1992: Karen L Kotloff; Steven Wasserman; S O'Donnell; Genevieve A Losonsky; Stanley J Cryz; Myron M Levine
Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial.
Infection and immunity 1992;60(10):4430-2.
1992: Stanley J Cryz; Myron M Levine; Genevieve A Losonsky; James B Kaper; B Althaus
Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.
Infection and immunity 1992;60(9):3916-7.
1992: T Olanratmanee; Myron M Levine; Genevieve A Losonsky; V Thisyakorn; Stanley J Cryz
Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.
The Journal of infectious diseases 1992;166(2):451-2.
1992: U Bruderer; Stanley J Cryz; U B Schaad; M Deusinger; John U Que; A B Lang
Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
The Journal of infectious diseases 1992;166(2):344-9.
1992: U Schürch; Stanley J Cryz; A B Lang
Scale-up and optimization of culture conditions of a human heterohybridoma producing serotype-specific antibodies to Pseudomonas aeruginosa.
Applied microbiology and biotechnology 1992;37(4):446-50.
1992: Stanley J Cryz
Live attenuated vaccines for human use.
Current opinion in biotechnology 1992;3(3):298-302.
1992: L F Fries; Daniel M Gordon; I Schneider; John C Beier; G W Long; M Gross; J U Que; Stanley J Cryz; J C Sadoff
Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.
Infection and immunity 1992;60(5):1834-9.
1992: Thomas K Held; Matthias Trautmann; M E Mielke; Hermann Neudeck; Stanley J Cryz; Alan S Cross
Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia.
Infection and immunity 1992;60(5):1771-8.
1992: U Bruderer; Emil Fürer; Stanley J Cryz; A B Lang
Properties determining the potential of naturally occurring and vaccine-induced human antibodies to protect against lethal infection of Pseudomonas aeruginosa.
Research in immunology 1992;143(2):165-74.
1991: U B Schaad; A B Lang; J Wedgwood; A Ruedeberg; John U Que; Emil Fürer; Stanley J Cryz
Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
Lancet 1991;338(8777):1236-7.
1991: A B Lang; U Schuerch; Stanley J Cryz
Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media.
Hybridoma 1991;10(3):401-9.
1991: A B Lang; U Bruderer; G Senyk; Tyrone L Pitt; J W Larrick; Stanley J Cryz
Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(9):3160-4.
1991: Stanley J Cryz; Emil Fürer; J C Sadoff; T Fredeking; John U Que; Alan S Cross
Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
The Journal of infectious diseases 1991;163(5):1055-61.
1991: Stanley J Cryz; Alan S Cross; J C Sadoff; A Wegmann; John U Que; Emil Fürer
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.
The Journal of infectious diseases 1991;163(5):1040-5.
1991: Carol O Tacket; Genevieve A Losonsky; David N Taylor; L S Baron; D Kopecko; Stanley J Cryz; Myron M Levine
Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
The Journal of infectious diseases 1991;163(4):901-4.
1991: Stanley J Cryz
Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.
Experientia 1991;47(2):146-51.
1991: D Favre; Stanley J Cryz; J F Viret
Cloning of the recA gene of Bordetella pertussis and characterization of its product.
Biochimie 1991;73(2-3):235-44.
1991: Stanley J Cryz; Emil Fürer; John U Que
Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.
Infection and immunity 1991;59(1):45-50.
1991: Stanley J Cryz; Emil Fürer; John U Que; J C Sadoff; M Brenner; U B Schaad
Clinical evaluation of an octavalent Pseudomonas aeruginosa conjugate vaccine in plasma donors and in bone marrow transplant and cystic fibrosis patients.
Antibiotics and chemotherapy 1991;44():157-62.
1990: David J Gottlieb; Stanley J Cryz; E Furer; John U Que; H Grant Prentice; A S Duncombe; M K Brenner
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.
Blood 1990;76(12):2470-5.
1990: Stanley J Cryz; Myron M Levine; James B Kaper; Emil Fürer; B Althaus
Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults.
Vaccine 1990;8(6):577-80.
1990: U Bruderer; Emil Fürer; Stanley J Cryz; A B Lang
Qualitative analysis of antibody binding. An in vitro assay for the evaluation and development of vaccines.
Journal of immunological methods 1990;133(2):263-8.
1990: Myron M Levine; C Ferreccio; Stanley J Cryz; E Ortiz
Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.
Lancet 1990;336(8720):891-4.
1990: Myron M Levine; David Hone; Carol O Tacket; C Ferreccio; Stanley J Cryz
Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
Research in microbiology 1990;141(7-8):807-16.
1990: Stanley J Cryz; Tyrone L Pitt; B Ayling-Smith; John U Que
Immunological cross-reactivity between Enterobacter aerogenes and Klebsiella capsular polysaccharides.
Microbial pathogenesis 1990;9(2):127-30.
1990: D A Herrington; L Van de Verg; S B Formal; T L Hale; BD Tall; Stanley J Cryz; E C Tramont; Myron M Levine
Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Vaccine 1990;8(4):353-7.
1990: Alan S Cross; J C Sadoff; E Furer; Stanley J Cryz
Escherichia coli and Klebsiella vaccines and immunotherapy.
Infectious disease clinics of North America 1990;4(2):271-82.
1990: Bruno Gottstein; N Müller; Stanley J Cryz; M Vogel; Isabelle Tanner; T Seebeck
Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain.
Parasite immunology 1990;12(2):163-74.
1990: Stanley J Cryz; Alan S Cross; J C Sadoff; Emil Fürer
Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.
Infection and immunity 1990;58(2):373-7.
1990: Stanley J Cryz
Klebsiella polysaccharide vaccines.
Advances in biotechnological processes 1990;13():87-103.
1990: A B Lang; Emil Fürer; G Senyk; J W Larrick; Stanley J Cryz
Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Human antibodies and hybridomas 1990;1(2):96-103.
1990: A B Lang; Emil Fürer; U Schürch; Alan S Cross; J W Larrick; Stanley J Cryz
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
Developments in biological standardization 1990;71():121-6.
1989: Stanley J Cryz; Emil Fürer; T Fredeking; Alan S Cross; J C Sadoff; John U Que
Effect of race and blood group on the immune response to bacterial polysaccharide and conjugate vaccines.
Lancet 1989;2(8678-8679):1533-4.
1989: Stanley J Cryz; Emil Fürer; L S Baron; K F Noon; F A Rubin; D J Kopecko
Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
Infection and immunity 1989;57(12):3863-8.
1989: A B Lang; Emil Fürer; J W Larrick; Stanley J Cryz
Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.
Infection and immunity 1989;57(12):3851-5.
1989: A B Lang; M T Ganss; Stanley J Cryz
Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping.
Infection and immunity 1989;57(9):2660-5.
1989: Donald E Woods; R Franklin; Stanley J Cryz; M Ganss; M Peppler; C Ewanowich
Development of a rat model for respiratory infection with Bordetella pertussis.
Infection and immunity 1989;57(4):1018-24.
1989: Stanley J Cryz; J C Sadoff; Emil Fürer
Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Microbial pathogenesis 1989;6(1):75-80.
1989: W Ripley Ballou; James F Young; Stanley J Cryz; J C Sadoff
The development of molecular vaccines against malaria sporozoites.
Advances in experimental medicine and biology 1989;251():295-313.
1989: Stanley J Cryz; J C Sadoff; Alan S Cross; Emil Fürer
Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans.
Antibiotics and chemotherapy 1989;42():177-83.
1989: Stanley J Cryz; J C Sadoff; John U Que
Conjugate vaccines against Pseudomonas aeruginosa and malaria.
Contributions to microbiology and immunology 1989;10():166-89.
1988: Stanley J Cryz; Alan S Cross; G C Sadoff; John U Que
Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
European journal of immunology 1988;18(12):2073-5.
1988: M Granström; B Wretlind; B Markman; Stanley J Cryz
Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
Journal of clinical microbiology 1988;26(11):2257-61.
1988: Stanley J Cryz; M Maag
Pseudomonas aeruginosa toxin-A-neutralising antibodies in normal human serum.
Lancet 1988;2(8615):855.
1988: John U Que; Stanley J Cryz; R Ballou; Emil Fürer; M Gross; James F Young; Gail Folena-Wasserman; L A Loomis; J C Sadoff
Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.
Infection and immunity 1988;56(10):2645-9.
1988: M Trautmann; Stanley J Cryz; J C Sadoff; Alan S Cross
A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
Microbial pathogenesis 1988;5(3):177-87.
1988: Myron M Levine; James B Kaper; D Herrington; J Ketley; Genevieve A Losonsky; Carol O Tacket; BD Tall; Stanley J Cryz
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.
Lancet 1988;2(8609):467-70.
1988: Stanley J Cryz; J C Sadoff; Emil Fürer
Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.
Infection and immunity 1988;56(7):1829-30.
1988: Stanley J Cryz; E Fürer
Further characterization of the Salmonella typhi Ty21a vaccine strain.
The Journal of infectious diseases 1988;157(6):1276-9.
1988: Stanley J Cryz; J C Sadoff; D Ohman; Emil Fürer
Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
The Journal of laboratory and clinical medicine 1988;111(6):701-7.
1988: J C Sadoff; W Ripley Ballou; L S Baron; W R Majarian; R N Brey; W T Hockmeyer; James F Young; Stanley J Cryz; J Ou; G H Lowell
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.
Science (New York, N.Y.) 1988;240(4850):336-8.
1988: Stanley J Cryz; E Fürer; Myron M Levine
[Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials].
Schweizerische medizinische Wochenschrift 1988;118(13):467-70.
1987: Stanley J Cryz
Prospects for the prevention and control of gram-negative nosocomial infections.
Vaccine 1987;5(4):261-5.
1987: Stanley J Cryz; Emil Fürer; J C Sadoff; R Germanier; Ira Pastan; M C Willingham; D J FitzGerald
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.
Reviews of infectious diseases 1987;9 Suppl 5():S644-9.
1987: Stanley J Cryz; Emil Fürer; Alan S Cross; A Wegmann; R Germanier; J C Sadoff
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
The Journal of clinical investigation 1987;80(1):51-6.
1987: Stanley J Cryz; A B Lang; J C Sadoff; R Germanier; Emil Fürer
Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.
Infection and immunity 1987;55(7):1547-51.
1987: T M Finn; Jakob Reiser; R Germanier; Stanley J Cryz
Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae.
Infection and immunity 1987;55(4):942-6.
1987: Stanley J Cryz
Progress in immunization against Pseudomonas aeruginosa and Klebsiella spp.
Pathology and immunopathology research 1987;6(2):147-52.
1987: Stanley J Cryz; Emil Fürer; J C Sadoff; R Germanier
A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Antibiotics and chemotherapy 1987;39():249-55.
1986: Stanley J Cryz; Emil Fürer; R Germanier
Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
Infection and immunity 1986;54(2):403-7.
1986: Stanley J Cryz; J C Sadoff; Emil Fürer; R Germanier
Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.
The Journal of infectious diseases 1986;154(4):682-8.
1986: Stanley J Cryz; Alan S Cross; Emil Fürer; N Chariatte; J C Sadoff; R Germanier
Activity of intravenous immune globulins against Klebsiella.
The Journal of laboratory and clinical medicine 1986;108(3):182-9.
1986: L E Elsheikh; R Bergman; Stanley J Cryz; B Wretlind
A comparison of different methods for determining elastase activity of Pseudomonas aeruginosa strains from mink.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology 1986;94(3):135-8.
1986: Stanley J Cryz; P M Mortimer; V Mansfield; R Germanier
Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.
Journal of clinical microbiology 1986;23(4):687-90.
1986: Stanley J Cryz; E Furer; J C Sadoff; R Germanier
Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.
Infection and immunity 1986;52(1):161-5.
1986: Stanley J Cryz; P Mortimer; Alan S Cross; Emil Fürer; R Germanier
Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
Vaccine 1986;4(1):15-20.
1985: Stanley J Cryz; Emil Fürer; R Germanier
Purification and vaccine potential of Klebsiella capsular polysaccharides.
Infection and immunity 1985;50(1):225-30.
1985: A R Ogaard; Stanley J Cryz; B P Berdal
Exotoxin A from various Pseudomonas aeruginosa cultures: in vitro activity measured by enzyme-linked immunosorbent assay (ELISA).
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology 1985;93(3):217-23.
1985: Stanley J Cryz; P M Meadow; Emil Fürer; R Germanier
Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
European journal of clinical microbiology 1985;4(2):180-5.
1985: Stanley J Cryz
New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections.
European journal of clinical microbiology 1985;4(2):153-5.
1985: Stanley J Cryz; Emil Fürer; R Germanier
Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
The Journal of infectious diseases 1985;151(4):665-71.
1984: Stanley J Cryz; Emil Fürer; R Germanier
Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide.
The Journal of infectious diseases 1984;150(6):817-22.
1984: L M Russell; Stanley J Cryz; R K Holmes
Genetic and biochemical evidence for a siderophore-dependent iron transport system in Corynebacterium diphtheriae.
Infection and immunity 1984;45(1):143-9.
1984: Stanley J Cryz; Emil Fürer; R Germanier
Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
Infection and immunity 1984;45(1):139-42.
1984: Stanley J Cryz; Tyrone L Pitt; Emil Fürer; R Germanier
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.
Infection and immunity 1984;44(2):508-13.
1984: Stanley J Cryz; Emil Fürer; R Germanier
Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.
Infection and immunity 1984;43(3):795-9.
1984: Stanley J Cryz; F Fürer; R Germanier
Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.
Infection and immunity 1984;43(1):440-1.
1983: Stanley J Cryz
Progress in immunization against Klebsiella infections.
European journal of clinical microbiology 1983;2(6):523-8.
1983: Stanley J Cryz; B H Iglewski
Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means.
Reviews of infectious diseases 1983;5 Suppl 5():S992-7.
1983: Stanley J Cryz; Emil Fürer; R Germanier
Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.
Infection and immunity 1983;40(2):659-64.
1983: Stanley J Cryz; L M Russell; R K Holmes
Regulation of toxinogenesis in Corynebacterium diphtheriae: mutations in the bacterial genome that alter the effects of iron on toxin production.
Journal of bacteriology 1983;154(1):245-52.
1983: Stanley J Cryz; Emil Fürer; R Germanier
Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
Infection and immunity 1983;39(3):1072-9.
1983: Stanley J Cryz; Emil Fürer; R Germanier
Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.
Infection and immunity 1983;39(3):1067-71.
1983: Stanley J Cryz; Emil Fürer; R Germanier
Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Developments in biological standardization 1983;53():67-72.
1983: Emil Fürer; Stanley J Cryz; R Germanier
Protection of piglets against neonatal colibacillosis based on antitoxic immunity.
Developments in biological standardization 1983;53():161-7.
1982: Stanley J Cryz; Emil Fürer; R Germanier
Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
Infection and immunity 1982;38(1):21-6.
1982: Stanley J Cryz; Emil Fürer; R Germanier
Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigens.
Journal of clinical microbiology 1982;16(1):41-5.
1982: D E Woods; Stanley J Cryz; R L Friedman; B H Iglewski
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.
Infection and immunity 1982;36(3):1223-8.
1982: Emil Fürer; Stanley J Cryz; F Dorner; J Nicolet; M Wanner; R Germanier
Protection against colibacillosis in neonatal piglets by immunization of dams with procholeragenoid.
Infection and immunity 1982;35(3):887-94.
1981: Stanley J Cryz; R L Friedman; O R Pavlovskis; B H Iglewski
Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A: biological, chemical, and immunochemical studies.
Infection and immunity 1981;32(2):759-68.
1980: Stanley J Cryz; R L Friedman; B H Iglewski
Isolation and characterization of a Pseudomonas aeruginosa mutant producing a nontoxic, immunologically crossreactive toxin A protein.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(12):7199-203.
1980: Stanley J Cryz; S L Welkos; R K Holmes
Immunochemical studies of diphtherial toxin and related nontoxic mutant proteins.
Infection and immunity 1980;30(3):835-46.
1980: Stanley J Cryz; B H Iglewski
Production of alkaline protease by Pseudomonas aeruginosa.
Journal of clinical microbiology 1980;12(1):131-3.
1980: Dennis Ohman; Stanley J Cryz; B H Iglewski
Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.
Journal of bacteriology 1980;142(3):836-42.